Aminoglycosides for the Treatment of Severe Infection Due to Resistant Gram-Negative Pathogens
Aminoglycosides are a family of rapidly bactericidal antibiotics that often remain active against resistant Gram-negative bacterial infections. Over the past decade, their use in critically ill patients has been refined; however, due to their renal and cochleovestibular toxicity, their indications i...
Saved in:
Main Authors: | Michaël Thy (Author), Jean-François Timsit (Author), Etienne de Montmollin (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment of Severe Infections Due to Metallo-Betalactamases <i>Enterobacterales</i> in Critically Ill Patients
by: Jean-François Timsit, et al.
Published: (2022) -
Cefiderocol Treatment for Severe Infections due to Difficult-to-Treat-Resistant Non-Fermentative Gram-Negative Bacilli in ICU Patients: A Case Series and Narrative Literature Review
by: Paul-Henri Wicky, et al.
Published: (2023) -
Antibiotic regimens for treatment of infections due to multidrug-resistant Gram-negative pathogens: An evidence-based literature review
by: Mandana Izadpanah, et al.
Published: (2015) -
Sensitization of Gram-Negative Bacteria to Aminoglycosides with 2-Aminoimidazole Adjuvants
by: Ashley N. Crotteau, et al.
Published: (2023) -
Treatment of Bloodstream Infections Due to Gram-Negative Bacteria with Difficult-to-Treat Resistance
by: Matteo Bassetti, et al.
Published: (2020)